Karen Bernstein, Director at Ovid Therapeutics Inc. (OVID), bought 20,000 shares at $6.23 ($125K) on 2018-08-14, disclosed to the SEC on 2018-08-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.23 | 10,000 | $62K | 50.0% |
| 2 | $6.23 | 10,000 | $62K | 50.0% |
| Total | $6.23 avg | 20,000 | $125K | 100% |